Grifols reported EUR1.9B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Arca Biopharma USD 1.47B 537M Dec/2025
aTyr Pharma USD 42M 37M Jul/2026
Bio Path USD 1000K 0 Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Immunic USD 64M 23M Dec/2025
Nektar Therapeutics USD 12.82B 11.96B Jul/2026